Information Library
Results for: Consulting - Product Development & Commercialization - Phase II/III
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Cancer Treatments and the Search for Value
White Paper — April 2, 2012
Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer -
Accelerating Success in Oncology
Brochure — March 9, 2012
New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity -
Quintiles Names New Global Head of Clinical & Data Operations
Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.
-
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Biomarkers in Alzheimers Disease
Presentation — March 17, 2011
The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. -
Exclusive Report From Scientific American
Hear from the Experts — November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
Healthcare's Future Tools
Hear from the Experts — November 8, 2010
Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report. -
Oncology Drug Development and Value-Based Medicine
White Paper — November 5, 2010
This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. -
Pharmacobiomics and Infectious Disease: Progress and Opportunities
White Paper — November 2, 2010
Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits.

